Schaffert Lena, Albersmeier Andreas, Winkler Anika, Kalinowski Jörn, Zotchev Sergey B, Rückert Christian
Technology Platform Genomics, CeBiTec, Bielefeld University, Bielefeld, Germany.
Department of Pharmacognosy, University of Vienna, 1090 Vienna, Austria.
Stand Genomic Sci. 2016 Dec 20;11:91. doi: 10.1186/s40793-016-0213-3. eCollection 2016.
HPA 177 is a Gram-positive, strictly aerobic, black pigment producing and spore-forming actinomycete, which forms branching vegetative hyphae and was isolated from the marine sponge . Actinomycete bacteria are prolific producers of secondary metabolites, some of which have been developed into anti-microbial, anti-tumor and immunosuppressive drugs currently used in human therapy. Considering this and the growing interest in natural products as sources of new drugs, actinomycete bacteria from the hitherto poorly explored marine environments may represent promising sources for drug discovery. As , isolated from the marine sponge, is a type strain of the recently described and rare genus , knowledge of the complete genome sequence enables genome analyses to identify genetic loci for novel bioactive compounds. This project, describing the 6.31 Mbp long chromosome, with its 5346 protein-coding and 73 RNA genes, will aid the project.
HPA 177是一种革兰氏阳性、严格需氧、产生黑色色素且形成芽孢的放线菌,它能形成分支的营养菌丝,是从海洋海绵中分离出来的。放线菌是次生代谢产物的丰富生产者,其中一些已被开发成目前用于人类治疗的抗菌、抗肿瘤和免疫抑制药物。考虑到这一点以及人们对天然产物作为新药来源的兴趣日益增加,来自迄今探索较少的海洋环境中的放线菌可能是有前景的药物发现来源。由于从海洋海绵中分离出的该菌株是最近描述的稀有属的模式菌株,完整基因组序列的知识使基因组分析能够识别新的生物活性化合物的基因位点。这个描述了631万碱基对长的染色体及其5346个蛋白质编码基因和73个RNA基因的项目,将有助于 项目。 (注:原文中“As,”表述有误,且最后“will aid the project”表述不完整,这里按正确理解翻译,但整体原文可能存在一些瑕疵影响翻译准确性。)